# Intravenous Lidocaine to Prevent Post-Fundal Pressure Headache During Cesarean Section

> **NCT07661758** · PHASE3 · RECRUITING · sponsor: **Tanta University** · enrollment: 680 (estimated)

## Conditions studied

- Intravenous Lidocaine
- Fundal Pressure
- Headache

## Interventions

- **DRUG:** Lidocaine IV
- **OTHER:** Saline 0.9%

## Key facts

- **NCT ID:** NCT07661758
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-11-02
- **Target enrollment:** 680 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07661758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07661758, "Intravenous Lidocaine to Prevent Post-Fundal Pressure Headache During Cesarean Section". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07661758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*